During infection, a host initially senses and responds to a pathogen, at the site of its entry and/or at sites of tissue damage, by initiating cascades of proinflammatory signals that activate resident host defenses and recruit additional immune effectors (41, 54, 58) . Many enteric bacterial pathogens, such as Listeria, Salmonella, and enteric Yersinia species, spread from initial sites of infection in the intestinal tract to systemic sites, while others, such as vibrios, clostridia, and enteropathogenic Escherichia coli, rarely leave the intestinal tract (24, 39, 53, 59) . Following infection with gram-negative enteric Yersinia pathogens, sites of inflammation include different regions of the intestines, as well as the associated lymphoid tissues of the Peyer's patches (PP) and mesenteric lymph nodes (MLN), and distal systemic sites, such as the spleen and liver (10, 17) . To establish infection and subvert host defenses at these sites, enteric Yersinia pathogens require a type III secretion system, which translocates virulence factors, called Yops (for Yersinia outer proteins), into host cells (5, 9, 19, 29, 30, 52, 57) .
Both the type III secretion system and the Yops are conserved among all three pathogenic Yersinia species, the enteric pathogens Yersinia pseudotuberculosis and Yersinia enterocolitica and Yersinia pestis, the causative agent of plague. Yops inhibit critical features of normal mammalian cell responses to bacteria; in cell culture, YopE, YopO, and YopH prevent phagocytosis by macrophages and neutrophils (18, 23, (44) (45) (46) ; YopH also blocks Ca 2ϩ signaling in neutrophils (2) , the oxidative burst of macrophages (6, 22) , and T-cell signaling, proliferation, and activation (1, 20, 48, 62) . YopJ suppresses TNF-␣ in cultured macrophages, presumably by deubiquitinating TRAF2, TRAF6, and IKK␤, which prevents activation of NF-B and mitogen-activated protein kinase pathways (38, 40, 63) , and promoting apoptosis of macrophages in cell culture and in the MLN of mice (36) . YopM causes a systemic depletion of natural killer (NK) cells after infection administered by intravenous injection and alters expression of interleukin-15 and the interleukin-15 receptor (25) . Thus, Yops target multiple features of the host immune response to promote survival of yersiniae during infection.
Since the dynamic interplay between host defenses and pathogens cannot be completely mimicked by cell culture systems, animal infection models provide valuable insights into how virulence factors thwart host defenses and reveal interactions among host defenses during infection (8, 25, 27, 36, 47) . We previously reported differences in the levels of attenuation of yopE and yopH mutants in single-strain mouse infections compared to competition infections with wild-type Y. pseudotuberculosis (30) . In single-strain infections, yopE and yopH mutants rarely colonized the spleen but generally colonized the intestines and PP at or near wild-type levels at 5 days postin-fection (30) . In contrast, when mice were coinfected with an equal mixture of yop mutant and wild-type Y. pseudotuberculosis bacteria, yopE and yopH mutants initially colonized the intestines and PP at 2 days postinfection but failed to survive to 5 days postinfection (30) . The decrease in yop mutant survival between days 2 and 5 correlated with systemic colonization of the spleen and liver by wild-type Y. pseudotuberculosis and with increasing signs of disease, such as weight loss and scruffiness (30) . While multiple mechanisms may explain how wild-type Y. pseudotuberculosis outcompetes yop mutants, the correlation between the development of systemic symptoms and yop mutant clearance suggests that coinfection with wild-type Y. pseudotuberculosis elicits a heightened host response that inhibits growth of strains lacking YopE or YopH.
Our findings from a variety of animal infection models indicate that yop mutants are outcompeted by wild-type Y. pseudotuberculosis because the mutants cannot combat the stronger proinflammatory response generated by infection with wild-type Y. pseudotuberculosis. Furthermore, by using novel animal infection models that isolate the effects of wild-type Y. pseudotuberculosis colonization in the spleen and liver from those due to wild-type Y. pseudotuberculosis present in the intestinal tract and PP, we identified an unexpected consequence of infection of the spleen and liver, which was that infection of these organs caused increased inflammation in the intestines, a connection that has been previously unrecognized.
MATERIALS AND METHODS
Bacterial strains. Y. pseudotuberculosis YPIII pIB1 (30) was used as the wildtype strain for all experiments, and all mutants were generated with this strain. This strain is virulent in mice but has a mutation in phoP (21) . The yopE and yopH unmarked deletion strains (30) , the kanamycin-resistant (Kan r ) wild-type YPIII strain (30, 34) , and the inv mutant strain (34) have been previously described. The yopMJ mutant was constructed by mating a Y. pseudotuberculosis yopJ mutant (36) with an E. coli SM10 pir strain containing the suicide plasmid pCVD442 carrying the yopM deletion as previously described (30) .
Mouse infections. All mice were 7-to 9-week-old females. BALB/c mice were purchased from Taconic, Germantown, NY, or the National Cancer Institute, Frederick, MD; gamma interferon (IFN-␥) Ϫ/Ϫ mice were purchased from The Jackson Laboratory, Bar Harbor, ME (stock no. 002286; IFN-␥ mutation on the BALB/c background). Orogastric infections were performed as previously described (30) . For oral-intraperitoneal (i.p.) infections, mice were orogastrically inoculated with 2 ϫ 10 9 CFU of wild-type or yopE or yopH mutant Y. pseudotuberculosis on day 0 and received an i.p. injection of 100 l of either phosphate-buffered saline (PBS) or 1 ϫ 10 6 CFU of the inv strain 2 days after oral inoculation. Mice were sacrificed by CO 2 asphyxiation 5 days post oral inoculation, and tissue samples were processed as previously described (30) . For mice infected with the inv mutant, samples were replica plated onto L plates containing 50-g/ml kanamycin to determine the level of colonization by each of the two strains.
Competition infections with wild-type Y. pseudotuberculosis were done as previously described (30) . For competition infections between yop mutants, yopE and yopH mutants were generated in the Kan r strain as previously described (30); the kanamycin cassette does not alter the virulence of strains (30) . The yopE Kan r or yopH Kan r strain was competed against the kanamycin-sensitive yopMJ strain, and the yopH Kan r strain was competed against the kanamycin-sensitive yopE strain. The Institutional Animal Care and Use Committee of Tufts University approved all animal procedures.
Lactoferrin assays. Fecal samples were collected in PBS plus 0.1% deoxycholate plus the proteinase inhibitors and homogenized as previously described (30) . The enzyme-linked immunosorbent assay (ELISA) protocol (35) was adapted to murine fecal samples as described elsewhere by L. K. Logsdon and J. Mecsas (submitted for publication). Levels of lactoferrin are expressed as nanograms of lactoferrin per gram of feces.
FACS analysis. Tissue samples were collected in RPMI medium (Gibco, Carlsbad, CA), and blood samples from cardiac puncture were collected in Microtainer brand tubes with EDTA (BD, Franklin Lakes, NJ). Tissue samples were mashed through a 70-m cell strainer (BD Falcon, Bedford, MA) with the rubber end of a 12-ml syringe, generating a single-cell suspension, and washed one time with RPMI medium. Cells were resuspended in fluorescence-activated cell sorter (FACS) buffer (PBS supplemented with 0.01% sodium azide and 1% fetal bovine serum) at a cell density of approximately 1 to 2 ϫ 10 6 cells/ml, and all further steps were performed at 4°C. Fc receptors were blocked with rat anti-mouse CD16/CD32 antibody (BD Pharmingen, San Diego, CA) and then stained with fluorescein isothiocyanate-conjugated anti-GR-1 (Ly-6G; BD Pharmingen) and PE-Cy7-conjugated anti-CD11b (BD Pharmingen) for 30 min to identify specific cell types. Samples were washed in FACS buffer, fixed in 1% paraformaldehyde for 15 min, and resuspended in FACS buffer. After blocking and straining, red blood cells in blood samples were lysed in PharMlyse (BD Pharmingen) and then fixed as described above. A FACScalibur (Becton Dickinson) was used for flow cytometry analysis of all samples. Cells were gated based on forward and side scatter to distinguish live from dead cells, and dead cells were eliminated from analysis. (30) . Immune cell functions altered in these mice include decreased activation of macrophages and NK cells, altered T-cell proliferation, and altered activation of cytokines and chemokines (14, 27) .
In IFN-␥ Ϫ/Ϫ mice, the CIs for yopE were 4-to 22-fold higher than those observed previously in BALB/c mice (30) in the intestinal tract and associated lymph tissues (Fig. 1A) . Moreover, the yopE mutant was recovered at the same level as wild-type Y. pseudotuberculosis, as indicated by a CI of 1, in the ceca, colons, and MLN of the IFN-␥ Ϫ/Ϫ mice. The lower CI in the IFN-␥ mice compared to the BALB/c mice is likely due to a lower limit of detection (1:250 to 1:500) in the IFN-␥ experiments compared to the limit of detection (1:100 to 1:200) in the previous experiments (30) . These results suggest that in BALB/c mice, the yopE mutant is susceptible to IFN-␥-regulated responses and that YopE protects Y. pseudotuberculosis from these responses.
In contrast to the yopE mutant, the absence of IFN-␥ did not completely restore the ability of the yopH mutant to compete with wild-type Y. pseudotuberculosis, although the CIs for the yopH mutant in the IFN-␥ Ϫ/Ϫ mice were 5-to 7.5-fold higher in the cecum and colon than previously seen in BALB/c mice (Fig. 1B) . These results indicate that other factors present in the IFN-␥ Ϫ/Ϫ mice also inhibit survival of the yopH mutant. The differences between the yopE and yopH mutants in the IFN-␥ Ϫ/Ϫ mice suggest that the yopE strain is more susceptible to IFN-␥-mediated responses than the yopH strain during coinfection with wild-type Y. pseudotuberculosis.
To determine if the lack of IFN-␥ responses increased the survival of the yop mutants in the absence of wild-type infection, single-strain oral infections with the yopE or yopH mutant or wild-type strain were performed with IFN-␥ Ϫ/Ϫ mice. Colonization by each strain was determined 5 days postinoculation and compared to our previous results with BALB/c mice (30) . Both yop mutant strains colonized the intestines of IFN-␥ Ϫ/Ϫ and BALB/c mice at similar levels ( Fig. 1C and D) . Thus, in the intestines, IFN-␥-mediated responses only deter the yop mutants in competition infections, indicating that these responses are elicited by wild-type Y. pseudotuberculosis. In contrast, levels of the yopE mutant in the PP and MLN and the yopH mutant in the MLN were higher in the IFN-␥ Ϫ/Ϫ mice than in the BALB/c mice ( Fig. 1C and D) , suggesting that IFN-␥-mediated responses hinder the yop mutants in the absence of a wild-type infection in lymph nodes. Levels of colonization of the spleen by the yopE mutant and the wild type, but not the yopH mutant, were significantly (240-fold and 50-fold, respectively) higher in IFN-␥ Ϫ/Ϫ mice than in BALB/c mice ( Fig. 1C , D, and E). Hence, IFN-␥ plays a significant role in inhibiting the yopE mutant and the wild type from reaching and/or surviving in the spleen. Despite increased systemic colonization, the IFN-␥ Ϫ/Ϫ mice did not succumb to infection earlier or show more severe signs of illness, such as weight loss and scruffiness, than BALB/c mice during the 5-day infection. In summary, during coinfections with wild-type Y. pseudotuberculosis, yop mutants survive better in the intestines in the absence of IFN-␥, suggesting that in BALB/c mice, wild-type infection triggers inflammatory defenses that hinder yop mutant survival.
Wild-type Y. pseudotuberculosis causes more inflammation than yop mutants in the intestines, PP, and blood. To verify that infection with wild-type Y. pseudotuberculosis elicits more inflammation than yop mutant strains, intestinal inflammation was measured following infection with these strains. Levels of lactoferrin, a protein secreted from the secondary granules of activated neutrophils (33, 43) , were measured in the feces of mice 1 day prior to infection with wild-type or yop mutant Y. pseudotuberculosis and on subsequent days postinfection. Maximal lactoferrin levels were reached 3 days after oral infection with wild-type Y. pseudotuberculosis ( Fig. 2A) . At this point, the feces of wild-type-infected mice exhibited significantly higher concentrations of lactoferrin than mice infected with the yopE or yopH mutants ( Fig. 2A) . Between days 3 and 5, lactoferrin levels in the feces of wild-type-infected mice fluctuated but remained significantly higher than in uninfected mice ( Fig. 2B and C). Mice receiving a mixed inoculum of the wild-type strain and a yop mutant strain were also tested to determine if wild-type Y. pseudotuberculosis elicits the same inflammatory response during competition infections. These mice developed elevated concentrations of lactoferrin in feces, which peaked at day 5 and were similar to those of wild-type-infected mice (Fig.  2C) . In contrast to mice infected with the wild-type strain, lactoferrin concentrations in the feces of mice infected with yopE or yopH mutant bacteria were never significantly different from those of uninfected mice (Fig. 2) .
A yopMJ deletion strain, which was used in the following experiments, was also tested in this assay. The yopMJ mutant strain has a colonization pattern similar to that of the yopE and yopH mutants, in that it colonizes the gastrointestinal (GI) Mice were orally inoculated with wild-type Y. pseudotuberculosis or yopE, yopH, or yopMJ mutant bacteria or a mixture of wild-type and yopE mutant bacteria. Fecal samples were collected daily and lactoferrin levels determined by ELISA. Each circle represents data from one mouse, and bars indicate the geometric means, which are also listed below the graph. Statistically significant differences ‫)ء(‬ compared to uninfected (un) mice were determined by unpaired Student t test (P Ͻ 0.01).
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tract and PP but rarely spreads to the spleen and liver. Mice infected with the yopMJ mutant had significantly higher amounts of lactoferrin than uninfected mice at day 3; however, this spike in levels was not sustained on day 4 or 5 ( Fig. 2) . To further assess the host response to infection with wildtype or yop mutant Y. pseudotuberculosis, granulocyte and macrophage or monocyte levels were measured in the PP and blood by flow cytometry analysis following oral inoculation of wild-type Y. pseudotuberculosis, various yop mutant strains, or a mixture of the wild type and a yopE mutant. The cellular markers CD11b and GR-1 (Ly-6G) were used to detect granulocytes (Cd11b ϩ /Gr-1 hi ) and blood monocytes or tissue macrophages (CD11b ϩ /Gr-1 lo ) (Fig. 3A ) (28) . At 5 days postinfection, granulocyte levels in the PP were significantly higher in mice infected with the wild type, a yopMJ mutant, or a mixture of wild-type and yopE mutant strains than in mice infected with the yopE or yopH mutant strain (Fig. 3B) . The granulocyte levels in the blood were significantly higher in mice infected with wild-type Y. pseudotuberculosis or a mixture of wild-type and yopE mutant bacteria than in mice infected with only yopE, yopH, or yopMJ mutant bacteria. Elevated levels of granulocytes in the blood correlated with the ability of wild-type Y. pseudotuberculosis, but not that of these yop mutants, to colonize systemic sites (Fig. 3C) . Although granulocyte levels in the PP and blood following infection with the yopE and yopH mutants did not reach the levels caused by wild-type infection, they were higher than in uninfected mice, indicating that infection with the yopE and yopH mutants triggered some inflammation ( Fig. 3B and C) .
At 3 days postinoculation, granulocyte levels in the PP of all infected mice were higher than in those of uninfected mice; however, significant differences were not detected between mice infected with the wild-type strain or the yop mutant strains (data not shown). Similarly, at both 3 and 5 days post- FIG. 3 . Levels of granulocytes in the PP and blood 5 days after infection with wild-type (wt) or yop mutant Y. pseudotuberculosis bacteria. Cells from the PP were stained with antibodies for GR-1 and CD11b and analyzed by FACS. Examples of histograms of granulocytes and monocytes/ macrophages gated for Cd11b and GR-1 expression from wild-type samples are shown (A). PP (B) and blood (C) samples were collected at day 5 from uninfected mice (un) or mice orally inoculated with either wild-type or yopE, yopH, or yopMJ mutant bacteria or an equal mixture of wild-type and yopE mutant (wtϩyopE) bacteria. The percentages of granulocytes of the total live cells are graphed; each circle represents data from one mouse, and bars indicate the geometric means. Statistically significant differences ‫)ء(‬ compared to wild-type-infected samples were determined by unpaired Student t test (P Ͻ 0.01). Colonization of the spleen and liver reduces yop mutant survival in the GI tract. In coinfections, yop mutant bacteria must compete with wild-type Y. pseudotuberculosis in the intestines and regional lymph tissues and must also confront and survive global effects from disseminated infection of the spleen and liver by wild-type Y. pseudotuberculosis. Since significantly more granulocytes were detected in the blood after infection with wild-type Y. pseudotuberculosis, we investigated whether colonization of the spleen and liver by Y. pseudotuberculosis increased inflammation and/or decreased yop mutant survival in other tissues. An oral-i.p. coinfection model was developed to separate the effects of intestinal colonization from the effects of deep tissue colonization of the spleen and liver. In this model, mice were first inoculated orally with wild-type or yop mutant bacteria and then superinfected by i.p. inoculation with an invasin-deficient Y. pseudotuberculosis strain (inv) which colonizes the spleen and liver but does not survive well in the intestines (34) . In i.p. infections, the inv strain had the same 50% lethal dose (41) as and colonized the spleen at levels comparable to those of wild-type Y. pseudotuberculosis (Fig. 4A and data not shown) (32, 34) but colonized the intestines and   FIG. 4 . Infection of the spleen by the Y. pseudotuberculosis inv mutant strain inhibits intestinal colonization by yopE and yopH mutant, but not wild-type, Y. pseudotuberculosis. The log CFU/g of tissue of the inv strain (■) recovered on day 5 from mice orally inoculated on day 0 with the yopE strain and injected i.p. on day 2 with the inv strain was calculated (A). Open symbols indicate that colonization by the inv mutant strain was below the limit of detection of 1 inv bacterium per 200 to 250 yopE bacteria. Colonization by the yopE (B) or yopH (C) mutant or wild-type (D) bacteria recovered on day 5 from mice orally inoculated on day 0 and injected i.p. on day 2 with PBS (OE) or the inv mutant strain (F) was determined. Each symbol represents data from one mouse, and bars indicate averages. The n-fold differences were calculated by dividing the average number of CFU/g of tissue of yopE or yopH mutant or wild-type bacteria in mice injected with PBS by the average number of CFU/g of tissue in mice injected with the inv mutant strain and are listed below each graph. Significant differences ‫)ء(‬ between levels of colonization in mice treated with PBS versus mice treated with inv were determined by the unpaired Student t test (P Ͻ 0.05). The log CFU/g of tissue of yopE and yopH mutant bacteria in oral competition infections with wild-type Y. pseudotuberculosis is represented by the symbol ϫ in panels B and C for comparison. These values were calculated from the previously reported competitive indices and in many cases are overestimates because the yop mutants were below the limit of detection (30) .
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PP poorly, if at all (Fig. 4A and data not shown). In the intestinal tract, the inv strain was detected at 2 to 3 log units of bacteria per g of tissue; in most cases, fewer than 50 inv colonies were detected in the intestinal contents collected (Fig.  4A ). This is significantly lower than the 4 to 6 log units of wild-type bacteria per g of tissue or 1,000 to 100,000 wild-type bacteria in the intestinal contents collected (Fig. 1E) (30) . Because wild-type Y. pseudotuberculosis was first detected in the spleen 2 days after oral inoculation (30), i.p. inoculums were administered at this time. Thus, in this oral-i.p. model the consequences of infection of the spleen and liver are reproduced with very low levels Y. pseudotuberculosis in the GI tract or PP. Mice were orally inoculated on day 0 with yopE, yopH, or wild-type Y. pseudotuberculosis. Two days later, half the mice received i.p. injections of the inv strain and half received injections of PBS. Five days after oral inoculation, colonization levels of the yopE, yopH, or wild-type bacteria were compared between mice that received an i.p. inoculation of the inv strain and those that received PBS. If infection of the spleen and liver hindered the survival of yop mutants in the intestinal tract, colonization by the yop mutants should be lower in mice that received the inv strain compared to those that received PBS. Indeed, levels of colonization by the yopE mutant decreased 7-to 11-fold throughout the intestinal tracts mice that received the inv strain (Fig. 4B, circles) compared to mice that received PBS (Fig. 4B, triangles) . The levels of yopE colonization in the intestinal tracts of mice that received the i.p. injection of the inv strain are similar to the levels of yopE colonization in oral competition experiments with the wild-type strain (30) . However, infection by the inv strain of the spleen and liver did not affect the ability of the yopE mutant to colonize the PP, and levels were higher than in oral competition infections with the wild-type strain. The yopH mutant colonization was also 10-fold lower in the ceca of mice that received the inv strain (Fig.  4C , circles) than in mice that received PBS (Fig. 4C, triangles) but did not decrease significantly in the rest of the intestines or the PP. This is in contrast to the lower levels of yopH colonization in the ileum and colon in oral competition infection with the wild-type strain (30) . In control experiments, colonization by wild-type yersiniae in the intestines remained the same or increased after i.p. injection of the inv strain (Fig. 4D) . Thus, yop mutant, but not wild-type, Y. pseudotuberculosis bacteria were susceptible to changes in the intestines due to infection of the spleen and liver.
To determine if bacterial products, such as lipopolysaccharide, present after i.p. injection altered yop mutant survival in the intestines, oral-i.p. infections were performed with heatkilled wild-type Y. pseudotuberculosis. The heat-killed Y. pseudotuberculosis did not alter intestinal survival of the yopE mutant, suggesting that active infection in the spleen and liver, not merely the presence of bacterial products, is required to decrease intestinal survival of the yopE mutant (data not shown).
Infection of the spleen and liver triggers increased inflammation in the intestines and bloodstream. To verify that spleen and liver infection with the inv strain increased levels of intestinal inflammation, fecal lactoferrin levels were measured in mice during oral-i.p. infections. At 5 days after oral inoculation, fecal lactoferrin levels were four-to fivefold higher in mice that received an oral inoculation of the yopE strain followed by an i.p. injection of the inv strain than in those that received PBS or in uninfected mice (Fig. 5) . Furthermore, infection by the inv strain in the spleen and liver induced levels of intestinal inflammation comparable to those caused by infection with wild-type Y. pseudotuberculosis (Fig. 2) .
To further examine how infection of the spleen and liver affects inflammation in different tissues, FACS analysis was used to measure granulocyte and monocyte/macrophage levels in the blood and PP of oral-i.p.-infected mice. Leukocyte levels in mice orally inoculated with the yopE mutant and i.p. injected with either the inv strain or PBS were compared to those in uninfected mice (Fig. 6 ). Mice inoculated with the yopE strain and injected with the inv strain had significantly more granulocytes in the blood than the PBS-injected control group (Fig.  6A) . These levels were similar to those seen in mice orally inoculated with the wild-type strain (Fig. 3C ), indicating that oral-i.p. infection generated systemic responses similar to those following oral inoculation with wild-type Y. pseudotuberculosis.
Levels of monocytes in the blood and of macrophages and granulocytes in the PP were not significantly different between uninfected and infected mice (Fig. 6B and data not shown) . These data, combined with the observation that colonization by the yopE mutant in the PP was not affected following i.p. inoculation of the inv strain, are consistent with the model in which yopE mutant survival decreases in tissues with increased levels of inflammation. on January 27, 2018 by guest http://iai.asm.org/ or by competing for colonization niches, for example, by competing for access to the PP through M cells or competing for a limiting nutrient. To assess whether yop mutant growth was inhibited by increased inflammation or by competition for niches in the PP, yop mutant levels were measured in infections in which equivalent numbers of Y. pseudotuberculosis bacteria were competing for colonization of the PP in the presence or absence of increased inflammation. In these experiments, colonization by the yopE and yopH mutants was compared in single-strain infections, in competition with the yopMJ strain, and in competition with each other. These three yop mutant strains rarely colonized systemic sites (Fig. 7 ) (30) but colonized the intestines and PP at similar levels (Fig. 7) ; however, the yopMJ mutant induced significantly more inflammation in these tissues than the yopE or yopH mutant ( Fig. 2 and 3) . Thus, if colonization by the yopE or yopH mutant bacteria was inhibited in inflamed tissues, then colonization by the yopE and/or yopH mutant bacteria should decrease in the presence of the yopMJ strain but not in the presence of each other. Alternatively, if the yopE or yopH mutant bacteria were prevented from gaining access to the PP by the presence of other invasive Y. pseudotuberculosis bacteria, then colonization by these mutants would decrease in the presence of each other and the yopMJ mutant strain.
In competition with the yopMJ mutant strain, yopE mutant colonization decreased 11-fold in the ileum and 40-fold in the PP compared to single-strain infections (Fig. 7A , compare circles to triangles), consistent with the increased inflammation observed in the intestines and PP following infection with the yopMJ strain ( Fig. 2 and 3) . Colonization by the yopE mutant in competition with the yopH mutant was not significantly different than in single-strain infections (Fig. 7C , compare circles to triangles). The 6.5-fold difference in the ileum was largely due to a single outlier. These results indicate that yopE mutant growth was inhibited by inflammation and not by the presence of Y. pseudotuberculosis strains competing for colonization niches in the ileum and PP.
Colonization by the yopH mutant was unchanged by competition with either yopMJ or yopE mutant bacteria in all tissues ( Fig. 7B and D) , indicating that these strains do not outcompete yopH mutants for colonization niches. This suggests that access to niches is not the cause of the decrease in yopH mutant survival in coinfection with wild-type Y. pseudotuberculosis. Furthermore, these results indicate that the yopH mutant is not susceptible to the increased inflammation induced by the yopMJ strain and that infection by the yopMJ strain does not generate the aspect of wild-type infection that suppresses yopH mutant survival. Combined with the IFN-␥ results, these data indicate that the yopE and yopH mutants are susceptible to different host factors in coinfections with wild-type Y. pseudotuberculosis.
DISCUSSION
A number of mutants in a variety of bacterial pathogens survive as well as the wild-type pathogen in single-strain infections but are outcompeted by the wild-type strain in competition infections (30, 36, 37, 55, 60) . Possible explanations for these results include an inability of the mutant to compete for sites of colonization or key nutrients or an inability to survive the host response to infection by the wild-type pathogen. Our results that the host defenses mounted in response to wild-type Y. pseudotuberculosis infection are stronger than those mounted after yop mutant infection provide an explanation for discrepancies between single-strain and competition infections. Furthermore, they illustrate important differences between the two infection models as assays for functions of virulence factors. In essence, single-strain infections measure the ability of a strain to access nutrients or niches and overcome host defenses resident in that tissue or recruited in response to infection by the mutant. In contrast, competition infections measure the ability of a strain to access limiting nutrients or niches and grow in inflamed tissues generated in response to a wild-type infection. Thus, the role of a Yop under wild-type infection (31) . In these experiments, while both pathogens were able to colonize the nasopharynx in single-strain infections, coinfection with both pathogens led to increased immune cell recruitment and decreased survival of S. pneumoniae in the nasopharynx (31) . Collectively, these two studies indicate that the host response to infection hinders mutant strains and competing pathogens and, by altering the composition of mucosal tissues, likely affects normal flora.
Surprisingly, infection of the spleen and liver by Y. pseudotuberculosis led to increased inflammation and decreased yop mutant survival in the GI tract, indicating a connection between systemic infection and the GI tract. Since a number of organisms, including Salmonella, Listeria, and Candida spp., disseminate from the intestines to distal organs (16, 24, 53, 59 ), this finding is important when considering host responses to disseminated infection and potential consequences for normal intestinal flora and tissues. It is interesting that the intestinal regions where yopE and yopH mutants were inhibited by systemic infection were the same tissues that these yop mutant strains colonized better in IFN-␥ Ϫ/Ϫ mice than in BALB/c mice in competition infections. This suggests that IFN-␥ mediates the effect systemic infection has on intestinal tissues. In fact, in preliminary experiments with IFN-␥ Ϫ/Ϫ mice, systemic infection by the inv strain did not suppress yopE mutant growth in the intestinal tract (data not shown). Although it is possible that the low levels of inv colonization in the intestinal tract promoted the increased intestinal inflammation, this seems unlikely since the levels were so low that they were undetectable in some mice, yet the levels of inflammation were higher than the levels triggered by colonization with yopE or yopH bacteria. Further analysis of cytokine and chemokine levels are aimed at identifying the signaling pathways that link the initial recognition of the infection with the extensive inflammation that occurs at other sites of infection.
In clinical cases of bacteremia and septic shock, intestinal symptoms are frequently seen but it is difficult to separate cause and effect because the source of bacteremia is usually the intestinal tract (15, 56) . However, in clinical cases of septicemia caused by transfusion of blood samples contaminated with Y. enterocolitica, diarrheal symptoms are observed within an hour after transfusion (4, 51) . Given the rapid onset of intestinal symptoms, it is unlikely that the bacteria spread from the bloodstream, infect the intestines, and cause these symptoms, when induction of intestinal inflammation in mice takes 48 to 36 h when the bacteria are directly inoculated into the intestinal tract (Fig. 2A) . These early signs of intestinal pathology support our findings that systemic infection increases intestinal inflammation.
In competition infections, yop mutants face increased inflammation due to systemic infection and the presence of wildtype yersiniae within the intestines and PP. There are several possible reasons why the presence of wild-type yersiniae in the intestines and PP induces more inflammation than the yopE and yopH mutants at 5 days postinfection, despite the observation that their levels are comparable in these tissues (30) . Wild-type Y. pseudotuberculosis colonized the intestines and PP in 10-fold higher numbers than the yopE and yopH mutants at 2 days postinfection (30) . This greater initial bacterial load likely fuels more inflammation potentially by stimulating Tolllike receptors (54) . In addition, YopE and YopH themselves could trigger increased inflammation by activating Toll-like receptors or stimulating immune cells that elicit inflammation; however, studies with cultured cells indicate that YopE and YopH reduce proinflammatory signals (48, 49, 61, 62) . Therefore, we favor the idea that the presence of YopE and YopH promotes bacterial survival, resulting in higher bacterial levels and increased inflammation.
The observation that yop mutants are more attenuated in a variety of infection models with stronger proinflammatory responses provides in vivo evidence that YopE and YopH overcome host defenses amassed in inflamed tissues. Interestingly, while cell culture data indicate that both YopE and YopH inhibit macrophage and granulocyte function (5, 23, 45) , our in vivo data indicate that the yopE and yopH mutants are susceptible to different host defenses. Under three experimental conditions, coinfection with wild-type Y. pseudotuberculosis, oral-i.p. infections, and coinfection with yopMJ, increased inflammation, as indicated by increased granulocytes, correlated with an inability of the yopE mutant to grow. Conversely, under two experimental conditions, coinfection of IFN-␥ Ϫ/Ϫ mice with wild-type Y. pseudotuberculosis and coinfection with the yopH mutant, a less aggressive proinflammatory response allowed the yopE mutant to grow. While granulocyte levels were measured to assess inflammation, it is likely that other mediators of inflammation also increase under these conditions. In fact, IFN-␥ itself does not recruit neutrophils, although it causes increased activation of neutrophils and alters other aspects of inflammation including cytokine and chemokine profiles that affect neutrophil recruitment (7, 12, 26, 27, 42, 50) . It is interesting that colonization of the yopE mutant was reduced 11-fold in the ileum at day 5 during competition with the yopMJ strain, although intestinal inflammation induced by yopMJ was only detected at day 3. It is possible that the increased granulocytes present at day 3 may hinder that yopE mutant to such a degree that colonization levels do not recover after the inflammation has resolved. Alternatively, other mediators of inflammation, such as macrophages, may be present in the intestinal tract at day 5 and inhibit survival of the On day 5, the number of CFU/g of tissue was determined for the yopE (OE) mutant in a single-strain infection or for the yopE (F) mutant in competition with yopH mutant bacteria (C) and for yopH (}) mutant bacteria in a single-strain infection and yopH (■) mutant bacteria in competition with the yopE mutant (D). The n-fold difference below each tissue equals the average number of CFU/g of yopE or yopH mutant bacteria singly versus in competition. Each symbol represents the colonization of one mouse, and bars indicate the geometric means. Statistically significant differences ‫)ء(‬ were determined by unpaired Student t test (P Ͻ 0.05).
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yopE mutants. Analysis of additional cell types, activation levels of immune cells, and examination of infection in mutant mouse strains will determine the roles of specific cell types in Yersinia infections and in targeting the yopE mutant. Growth of the yopH mutant was impeded in some, but not all, tissues with increased granulocytes. Specifically, infection with both the wild-type and yopMJ mutant strains induced recruitment of granulocytes to the PP, but only wild-type infection inhibited survival of the yopH mutant. Since infection with the yopMJ strain does not reproduce all aspects of wildtype Y. pseudotuberculosis infection, further analysis of differences in the immune response to infection with wild-type or yopMJ bacteria should suggest the host factors that eliminate the yopH mutant in competitions with wild-type Y. pseudotuberculosis.
Our studies indicated that lower IFN-␥ levels increased wild-type Y. pseudotuberculosis colonization in the spleen. These results are consistent with previous reports that IFN-␥ Ϫ/Ϫ mice are more susceptible to infection with other pathogens, including Mycobacterium species, Cryptosporidium parvum, and Francisella tularensis (11, 13, 27) . However, in previous studies with intravenous inoculation of Y. enterocolitica, antibody depletion of IFN-␥ did not alter systemic colonization (3) . This difference could be due to the use of different animal models or different routes of inoculation, or Y. pseudotuberculosis may be more susceptible to IFN-␥-mediated responses than Y. enterocolitica.
In summary, infection with wild-type Y. pseudotuberculosis triggered a stronger proinflammatory response than infection with the yopH and yopE mutants, and thus, competition infections measure the ability of a yop mutant to survive in the face of a heighten immune response. Therefore, functions of Yops in combating inflammation and other changes induced by wildtype are better assessed in competition infections. However, in cases where wild-type pathogens suppress immune function, such as during latent infections, coinfection with mutant strains could lead to increased inflammation and decreased survival of both strains. Thus, understanding how wild-type and mutant strains modulate host defenses in single-strain infections and coinfections is critical in investigating the function of virulence factors in these infection models.
